Male Hormone Replacement Therapy

Andropause is the gradual decline of testosterone and other hormones that occurs in men as they age — sometimes called the male menopause, though the process differs significantly from female menopause. Where menopause involves a relatively abrupt drop in estrogen over a period of years, andropause is characterized by a slow, steady decline in testosterone of approximately 1% per year beginning around age 30. Symptoms develop gradually and are often attributed to other causes — fatigue, reduced libido, weight gain, mood changes, reduced muscle mass, brain fog, and sleep disruption are all common but easily dismissed. Andropause does not involve a complete cessation of hormone production as menopause does — most men retain some testosterone production indefinitely — but the cumulative decline over decades can reach the point where symptoms significantly affect quality of life and health outcomes

Progesterone is not exclusively a female hormone — men produce it in the adrenal glands and testes, and it plays several important roles in male physiology. The most clinically significant is its function as a natural aromatase inhibitor. Aromatase is the enzyme that converts testosterone into estrogen in peripheral tissues including fat, liver, and brain — a normal process in small amounts, but one that becomes problematic when it proceeds excessively. Progesterone inhibits aromatase activity, helping maintain the testosterone-to-estrogen ratio that supports male health. Progesterone also has prostate-protective effects — it counteracts the proliferative effects of estrogen on prostate tissue and supports healthy PSA levels. Additionally, progesterone contributes to neurological health in men through myelin sheath support and GABA-A receptor activity, providing cognitive and mood benefits similar to those seen in women.

Excessive aromatization of testosterone to estrogen — a condition called estrogen dominance in men — produces a recognizable cluster of symptoms. Gynecomastia (breast tissue development) is the most visually obvious sign. Increased abdominal and chest fat accumulation is common, as is reduced libido and erectile dysfunction — paradoxically, despite higher estrogen and relatively lower testosterone. Moodiness, irritability, and emotional lability reflect estrogen's excitatory effects without adequate testosterone to balance them. Metabolic effects include increased insulin resistance and difficulty maintaining lean body mass. Elevated estrogen in men is also associated with cardiovascular risk through its effects on clotting factors and fluid retention. Conventional aromatase inhibitor medications (anastrozole, exemestane) are sometimes prescribed to address this, but bioidentical progesterone offers a more physiological approach by working through the body's own hormonal pathways.

In clinical practice, progesterone is added to testosterone replacement therapy in small doses calibrated to the testosterone dose — typically approximately 2.5 milligrams of progesterone for every 40 milligrams of testosterone. This ratio helps maintain the aromatase-inhibiting effect of progesterone proportional to the testosterone load being converted. Gen-Pro™, a bioidentical progesterone in a highly absorbable transdermal base delivering 25 milligrams per pump, is typically used one to three times weekly in men on TRT, depending on their testosterone dose and estradiol levels. Because the goal in men is aromatase inhibition rather than the systemic progesterone replacement needed in women, lower and less frequent dosing is appropriate. Monitoring estradiol levels alongside testosterone allows dose adjustments as needed to maintain optimal hormone balance.